Please select the eligibility criteria that correspond to the clinical trial below.
Title: Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation
Brief Summary: The recent Surgeon General's Report calls for effective and readily available treatment approaches to help adolescent smokers interested in quitting. Schools are an ideal venue for connecting adolescent smokers with smoking cessation assistance. This study will adapt the Craving to Quit (C2Q) smartphone app, which integrates mindfulness training into a smoking cessation program, for teen smokers (C2Q-Teen). We will test how well this novel app helps teens stop smoking compared to another teen smoking cessation app that does not include mindfulness training, and to written cessation information alone. If effective, the C2Q-Teen would be relatively easy to disseminate widely and have tremendous public health significance


Options:
A: Inclusion Criteria:

1. aged 18 and older;
2. smokes at least 10 cigarettes daily and has done so for at least the past 12 months;
3. wants to quit smoking in the next 30 days;
4. willing to be randomly assigned to either group;
5. willing and able to speak and read in English;
6. willing and medically eligible to use nicotine replacement therapy (NRT),
7. currently resides in the U.S., and expects to continue for at least 12 months;
8. not participating in other smoking cessation interventions;
9. has regular access to a telephone.
10. has regular access to an email address.

Exclusion Criteria:

* The Exclusion criteria are the opposite of the Inclusion criteria listed above. In addition, the following exclusion criteria also apply:

  1. another member of household enrolled in the study;
  2. currently using medication or nicotine replacement products to help with quitting smoking;
  3. currently using any non-cigarette tobacco products;
  4. pregnant or breastfeeding;
  5. had a heart attack in last 30 days;
  6. within the last 6 months, diagnosed with angina, heart pain, or irregular heartbeat;
  7. serious adverse reactions to nicotine patches including anaphylaxis and related symptoms such as hives, respiratory difficulty, and/or angioedema.
B: Inclusion Criteria:

* First year medical students who agree to participate in the study and are officially registered in the mindfulness course at the school of medicine - Federal University of Juiz de Fora, Brazil

Exclusion criteria:

* Students who refused to participate
C: Inclusion Criteria:

1. Current or history of head and neck, lung, breast, gastrointestinal, or genitourinary cancer
2. Age 18 or older
3. Smoking 1 cigarette or more per day at screening visit
4. English speaking and have a telephone
5. Willing to provide informed consent and agree to all assessments and study procedures
6. Recommended for and agreed to treatment with varenicline through the Tobacco Treatment Program
7. Plan to receive treatment for head and neck, lung, breast, gastrointestinal, or genitourinary cancer, currently undergoing treatment, or in follow-up care at M.D. Anderson Cancer Center

Exclusion Criteria:

1. Anticipated hospitalization of 2 weeks or longer
2. Planned total laryngectomy
3. Current use of bupropion, nortriptyline, clonidine or nicotine replacement therapy
4. Currently receiving other forms of smoking cessation treatment
5. Severe levels of depressive symptoms, vegetative symptoms, and/or symptoms related to psychiatric disorders that place participant at risk for harm or require immediate treatment
6. Currently pregnant or lactating
7. Has received treatment in the TTP
8. History or/current medical condition, or any other factor that , in the judgment of the PI would likely preclude completion of study requirements
D: Inclusion Criteria:

* enrolled in grade 9-12
* smoked at least 5 cigarettes on average per day for the past 7 days
* interested in quitting smoking in the next three weeks
* have a smartphone on iPhone or Android platforms
* English-speaking

Exclusion Criteria:

* unable or unwilling to provide informed assent
* diagnosis of a serious psychiatric illness during the past 5 years
* developmental delay that would prevent study participation

Answer: D